Skip to content
cystinosis
EntityQ1149042· pop 22· linked from 175 articles

cystinosis

Sign in to save

Also known as Cystine storage disease, Cystinosis (disorder), Cystinosis (disorder) [Ambiguous], Cystinosis [dup] (disorder), Cystine disease, Protein defect of cystin transport, Cystinoses, Cystine diathesis

Cystinosis is a lysosomal storage disease characterized by the abnormal accumulation of free cystine, the oxidized dimer of the amino acid cysteine in lysosomes, eventually leading to intracellular crystal formation throughout the body, e.g. in kidneys.

Key facts

Medical condition.name
Cystinosis
Medical condition.synonyms
Cystine storage disease, Abderhalden–Lignac–Kaufmann disease, Abderhalden–Kaufmann–Lignac syndrome
Medical condition.image
Cystine-skeletal.png
Medical condition.caption
Chemical structure of cystine formed from L-cysteine (under biological conditions)

via Wikipedia infobox

Research

1,873 papers

via PubMed

~17 min read

Encyclopedic overview

19 sections
Contents
  • Classification
  • Symptoms and signs
  • Crystal morphology and identification
  • Pathophysiology
  • Diagnosis
  • Complications
  • Genetics
  • Diagnosis
  • Management
  • Treatment
  • Investigational treatments
  • Gene therapy
  • CRISPR gene editing
  • Pharmacological therapies (Beyond Cysteamine)
  • Prognosis
  • History
  • See also
  • References
  • External links

Cystinosis is a lysosomal storage disease characterized by the abnormal accumulation of free cystine, the oxidized dimer of the amino acid cysteine in lysosomes, eventually leading to intracellular crystal formation throughout the body, e.g. in kidneys.

It is genetically inheritable in the autosomal recessive fashion via CTNS (AR) gene. It characterized by systemic accumulation of the amino acid cystine within lysosomes, proximal tubulopathy and by progressive chronic kidney disease. If untreated, it leads to progressive cellular dysfunction and multiorgan involvement. The disease most commonly presents in infancy with renal Fanconi syndrome and, without treatment, progresses to end-stage kidney disease (ESKD) in childhood. Extra-renal manifestations affecting the eyes, thyroid, muscle, pancreas, and central nervous system may develop later in life. Early diagnosis and lifelong cystine-depleting therapy improve growth, delay progression to ESKD, and reduce many systemic complications. Nevertheless, despite treatment, the mean age at death for individuals born between 1985 and 1999 has been 29 years.

Excerpted from Wikipedia’s “cystinosis” article, available under the CC BY-SA 4.0 licence.

Gallery (4)